Literature DB >> 20816413

The neurobiology of migraine.

Andrew Charles1, K C Brennan.   

Abstract

The understanding of migraine has moved well beyond its traditional characterization as a "vascular headache." In considering the basic neurobiology of migraine, it is important to begin with the concept of migraine as not merely a headache, but rather a heterogeneous array of episodic symptoms. Among the array of phenomena experienced by migraine patients are visual disturbances, nausea, cognitive dysfunction, fatigue, and sensitivity to light, sound, smell, and touch. These symptoms may occur independently or in any combination, and in some patients occur even in the absence of headache. The diversity and variability of symptoms experienced by migraine patients belies a complex neurobiology, involving multiple cellular, neurochemical, and neurophysiological processes occurring at multiple neuroanatomical sites. Migraine is a multifaceted neurobiological phenomenon that involves activation of diverse neurochemical and cellular signaling pathways in multiple regions of the brain. Propagated waves of cellular activity in the cortex, possibly involving distinct glial and vascular signaling mechanisms, can occur along with activation of brainstem centers and nociceptive pathways. Whether different brain regions become involved in a linear sequence, or as parallel processes, is uncertain. The modulation of brain signaling by genetic factors, and by sex and sex hormones, provides important clues regarding the fundamental mechanisms by which migraine is initiated and sustained. Each of these mechanisms may represent distinct therapeutic targets for this complex and commonly disabling disorder.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816413      PMCID: PMC5494713          DOI: 10.1016/S0072-9752(10)97007-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  77 in total

1.  Modulation of neuronal activity in the nucleus raphé magnus by the 5-HT(1)-receptor agonist naratriptan in rat.

Authors:  Jens Ellrich; Karl Messlinger; Chen Yu Chiang; James W Hu
Journal:  Pain       Date:  2001-02-15       Impact factor: 6.961

2.  Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura.

Authors:  Marsha Smith; Didier Cros; Volney Sheen
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

3.  Local potassium signaling couples neuronal activity to vasodilation in the brain.

Authors:  Jessica A Filosa; Adrian D Bonev; Stephen V Straub; Andrea L Meredith; M Keith Wilkerson; Richard W Aldrich; Mark T Nelson
Journal:  Nat Neurosci       Date:  2006-11       Impact factor: 24.884

Review 4.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

5.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

6.  Pronounced hypoperfusion during spreading depression in mouse cortex.

Authors:  Cenk Ayata; Hwa Kyoung Shin; Salvatore Salomone; Yasemin Ozdemir-Gursoy; David A Boas; Andrew K Dunn; Michael A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  2004-10       Impact factor: 6.200

7.  Functional MRI-BOLD of brainstem structures during visually triggered migraine.

Authors:  Y Cao; S K Aurora; V Nagesh; S C Patel; K M A Welch
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

8.  C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.

Authors:  Anna Richards; Arn M J M van den Maagdenberg; Joanna C Jen; David Kavanagh; Paula Bertram; Dirk Spitzer; M Kathryn Liszewski; Maria-Louise Barilla-Labarca; Gisela M Terwindt; Yumi Kasai; Mike McLellan; Mark Gilbert Grand; Kaate R J Vanmolkot; Boukje de Vries; Jijun Wan; Michael J Kane; Hafsa Mamsa; Ruth Schäfer; Anine H Stam; Joost Haan; Paulus T V M de Jong; Caroline W Storimans; Mary J van Schooneveld; Jendo A Oosterhuis; Andreas Gschwendter; Martin Dichgans; Katya E Kotschet; Suzanne Hodgkinson; Todd A Hardy; Martin B Delatycki; Rula A Hajj-Ali; Parul H Kothari; Stanley F Nelson; Rune R Frants; Robert W Baloh; Michel D Ferrari; John P Atkinson
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

9.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation.

Authors:  Micaela Zonta; María Cecilia Angulo; Sara Gobbo; Bernhard Rosengarten; Konstantin-A Hossmann; Tullio Pozzan; Giorgio Carmignoto
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

10.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

Authors:  Maurizio De Fusco; Roberto Marconi; Laura Silvestri; Luigia Atorino; Luca Rampoldi; Letterio Morgante; Andrea Ballabio; Paolo Aridon; Giorgio Casari
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  10 in total

1.  Altered brainstem auditory evoked potentials in a rat central sensitization model are similar to those in migraine.

Authors:  Xianghong Arakaki; Gary Galbraith; Victor Pikov; Alfred N Fonteh; Michael G Harrington
Journal:  Brain Res       Date:  2014-03-27       Impact factor: 3.252

2.  The brain effect of the migraine attack: an ASL MRI study of the cerebral perfusion during a migraine attack.

Authors:  Silvia Corno; Luca Giani; Maria Marcella Laganà; Francesca Baglio; Claudio Mariani; Leonardo Pantoni; Carlo Lovati
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

3.  Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates.

Authors:  Frederick R Taylor; Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

4.  Olfactory bulbus volume and olfactory sulcus depth in migraine patients: an MRI evaluation.

Authors:  Adil Doğan; Nuray Bayar Muluk; Mehmet Hamdi Şahan; Neşe Asal; Mikail Inal; Ufuk Ergün
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-06       Impact factor: 2.503

5.  sec-Butylpropylacetamide (SPD) has antimigraine properties.

Authors:  Dan Kaufmann; Emily A Bates; Boris Yagen; Meir Bialer; Gerald H Saunders; Karen Wilcox; H Steve White; K C Brennan
Journal:  Cephalalgia       Date:  2015-11-13       Impact factor: 6.292

6.  A hypothetical proposal for association between migraine and Meniere's disease.

Authors:  Brooke Sarna; Mehdi Abouzari; Harrison W Lin; Hamid R Djalilian
Journal:  Med Hypotheses       Date:  2019-10-12       Impact factor: 1.538

Review 7.  Caffeine and Primary (Migraine) Headaches-Friend or Foe?

Authors:  Karl B Alstadhaug; Anna P Andreou
Journal:  Front Neurol       Date:  2019-12-03       Impact factor: 4.003

8.  Headache Medicine Grand Challenge: Headache: A New Frontier, A New Challenge.

Authors:  Frederick G Freitag
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-09

9.  Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake.

Authors:  Erika Liktor-Busa; Kiera T Blawn; Kathryn L Kellohen; Beth M Wiese; Vani Verkhovsky; Jared Wahl; Anjali Vivek; Seph M Palomino; Thomas P Davis; Todd W Vanderah; Tally M Largent-Milnes
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

10.  A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects.

Authors:  Michael J Fossler; Virginia Schmith; Stephen A Greene; Lauren Lohmer; Michael S Kramer; Kelly Arscott; Ian E James; Mark A Demitrack
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.